Skin side effects of melanoma drugs | 22 min
Cutaneous toxicities are common in melanoma patients undergoing treatment with targeted or immune therapy, and dermatological assessment is advised in the initial stage of…
ASCO 2020: Melanoma highlights through an Australian lens | 66 min
In this engaging case-study based panel discussion, our multidisciplinary experts reveal the rationale behind their clinical decision making. They discuss breakthrough melanoma trials, including…
Emerging therapies in advanced melanoma in 2020 | 55 min
In the rapidly evolving treatment landscape for advanced melanoma, medical oncologists now have a suite of treatments to choose from for their patients. In…
Updates to the treatment of actinic keratosis | 12 min
Non-surgical treatment of skin cancers can be an option depending on tumour type, extent of disease and localisation. In this presentation, Dermatologist A/Prof Guitera…
Classification and grading of benign melanocytic nevi | 56 min
In this conversational lecture from Dermpedia.org, Prof Artur Zembowicz and MIA’s Prof Richard Scolyer discuss the historical overview of dysplastic nevus and recent conclusions…
Melanoma in children and adolescents | 18 min
Melanoma is one of the most common human malignancies, however we don’t often think of it as a disease that occurs in children. Although…
Neoadjuvant therapy in the management of melanoma | 6 min
In this brief video interview by PracticeUpdate, MIA’s Prof Georgina Long talks to Correspondent Dr Aman Shah about the neoadjuvant setting in melanoma and…
When should I refer to a melanoma clinic? | 34 mins
In the evolving treatment landscape of melanoma, it is important for GPs and Dermatologists to be confident in managing or knowing when to refer…
Integrating tumour banking and molecular testing into the diagnostic workflow | 22 min
This presentation was recorded at the 1st Australasian Ocular Melanoma Summit. PRESENTER Dr Svetlana Cherepanoff Staff Specialist, Anatomical Pathology (SydPath), St Vincent’s Hospital Sydney